You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 和譽-B漲5% 與禮來心臟代謝疾病等重大疾病藥物簽訂合作協議
格隆匯 01-19 12:07
格隆匯1月19日丨和譽-B(2256.HK)午間收漲5.18% ,報8.2港元,總市值58億港元。和譽-B1月18日公佈,其附屬和譽醫藥已與禮來訂立一份全球合作及獨家許可協議,以進一步針對心臟代謝疾病等未被滿足醫療需求的重大疾病中的未公開靶點,在新型小分子藥物的發現、開發及潛在商業化領域開展合作。據此,和譽醫藥將負責利用其專有的藥物研發平台進一步開展小分子藥物的發現和開發,該些小分子藥物將作用於新型且具有挑戰性的藥物靶點。禮來將通過提供與此靶點關聯的早前發現資料及若干額外的疾病知識及技能以參與到研發工作中。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account